SINGAPORE & SAN CARLOS, Calif.--(BUSINESS WIRE)--Engine Biosciences (“Engine”) today announced the successful completion of an oversubscribed $43 million Series A funding round. Engine identifies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback